Literature DB >> 21510732

Pulmonary veno-occlusive disease: advances in clinical management and treatments.

Alice Huertas1, Barbara Girerd, Peter Dorfmuller, Dermot O'Callaghan, Marc Humbert, David Montani.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare disorder that can be misdiagnosed as idiopathic pulmonary arterial hypertension (PAH) and accounts for 5-10% of cases initially considered as idiopathic PAH. PVOD and idiopathic PAH share a similar clinical presentation, genetic background and hemodynamic profile. A definite diagnosis of PVOD necessitates a surgical biopsy, but since it represents a high-risk procedure in these patients, it is contraindicated. Therefore, a noninvasive diagnostic approach using chest high-resolution computed tomography, arterial blood gas analysis, pulmonary function tests and bronchoalveolar lavage is helpful to detect PVOD. PVOD is characterized by a poor prognosis and the possibility of developing severe pulmonary edema with specific PAH therapy. Lung transplantation remains the treatment of choice.

Entities:  

Mesh:

Year:  2011        PMID: 21510732     DOI: 10.1586/ers.11.15

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  12 in total

Review 1.  Pulmonary veno-occlusive disease: a misnomer?

Authors:  Cindy R Miller
Journal:  Pediatr Radiol       Date:  2012-02-05

Review 2.  Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?

Authors:  Alison M MacKenzie; Andrew J Peacock
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

3.  Pulmonary hypertension nosography: are all patients classifiable?

Authors:  Elena Torricelli; Mariaelena Occhipinti; Federico Lavorini; Chiara Cresci; Chiara Arcangeli; Edoardo Cavigli; Francesca Bigazzi; Massimo Pistolesi
Journal:  Intern Emerg Med       Date:  2017-06-30       Impact factor: 3.397

4.  Pulmonary veno-occlusive disease: an uncommon cause of pulmonary hypertension.

Authors:  Kyle Masters; Steven Bennett
Journal:  BMJ Case Rep       Date:  2013-02-01

5.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

6.  Pulmonary veno-occlusive disease as a cause of pulmonary arterial hypertension.

Authors:  Mateo Porres-Aguilar; Ihsan Al-Bayati; Mateo Porres-Muñoz; Osvaldo Padilla; Saad H Syed; Kevin Lowder; Komola Azimova; Jerry Fan; Debabrata Mukherjee; Aamer Abbas
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

7.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

8.  Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease.

Authors:  Heidi Lederer; Bettina Muggli; Rudolf Speich; Ula Treder; Hans Stricker; Jeroen Goede; Silvia Ulrich; Simon F Stämpfli; Alexander Breitenstein
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

9.  Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Authors:  Carol R Reinero; L Ari Jutkowitz; Nathan Nelson; Isabelle Masseau; Samuel Jennings; Kurt Williams
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

10.  Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension.

Authors:  Said Hajouli; Muhamad Alhaj Moustafa; Jessica S Wang Memoli
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.